Female pattern hair loss in complete androgen insensitivity syndrome

British Journal of Dermatology

Volumn 162, Issue 5, 2010, Pages 1135-1137

  Cousen, P ^a   Messenger, A ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Complete androgen insensitivity syndrome; Female pattern hair loss

Indexed keywords

ANDROSTANOLONE; ESTROGEN; FINASTERIDE; MINOXIDIL; SPIRONOLACTONE; TESTOSTERONE;

ADULT; ANDROGEN INSENSITIVITY SYNDROME; ARTICLE; CASE REPORT; CHROMOSOME ANALYSIS; CLINICAL FEATURE; FAMILY HISTORY; FEMALE; FEMALE PATTERN HAIR LOSS; GENITAL MALFORMATION; HAIR LOSS; HUMAN; KARYOTYPE; PRIORITY JOURNAL;

ALOPECIA; ANDROGEN-INSENSITIVITY SYNDROME; ANDROGENS; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 77951217015     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09661.x     Document Type: Article

References (19)

1. Birch MP, Messenger JF, Messenger AG. Hair density, hair diameter and the prevalence of female pattern hair loss. Br J Dermatol 2001 144 : 297 304.
2. Norwood OT. Incidence of female androgenetic alopecia (female pattern alopecia). Dermatol Surg 2001 27 : 53 4.
3. Whiting DA, Waldstreicher J, Sanchez M et al. Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies: results of finasteride 1 mg treatment of men and postmenopausal women. J Investig Dermatol Symp Proc 1999 4 : 282 284. (Pubitemid 30085821)
4. Messenger AG, Sinclair R. Follicular miniaturization in female pattern hair loss: clinicopathological correlations. Br J Dermatol 2006 155 : 926 930. (Pubitemid 44564500)
5. Hughes IA, Deeb A. Androgen resistance. Best Pract Res Clin Endocrinol Metab 2006 20 : 577 598. (Pubitemid 44849163)
6. Sinclair R, Greenland KJ, van Egmond S et al. Men with Kennedy disease have a reduced risk of androgenetic alopecia. Br J Dermatol 2007 157 : 290 294. (Pubitemid 47083864)
7. Baldwin LG, Gafford JA. Arrhenoblastoma case report. Endocrinology 1936 20 : 373 382.
8. Kantner AE, Ragins AB. Arrhenoblastoma of the ovary. Am J Obstet Gynecol 1941 42 : 1061 1066.
9. Hamilton JB. Male hormone stimulation is pre-requisite and an incitant in common baldness. Am J Anat 1942 71 : 451 480.
10. Futterweit W, Dunaif A, Yeh HC et al. The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia. J Am Acad Dermatol 1988 19 : 831 836. (Pubitemid 18260991)
11. Vexiau P, Chaspoux C, Boudou P et al. Role of androgens in female-pattern androgenetic alopecia, either alone or associated with other symptoms of hyperandrogenism. Arch Dermatol Res 2000 292 : 598 604. (Pubitemid 32112967)
12. Cela E, Robertson C, Rush K et al. Prevalence of polycystic ovaries in women with androgenic alopecia. Eur J Endocrinol 2003 149 : 439 442. (Pubitemid 37461526)
13. Thornton MJ, Nelson LD, Taylor AH et al. The modulation of aromatase and estrogen receptor alpha in cultured human dermal papilla cells by dexamethasone: a novel mechanism for selective action of estrogen via estrogen receptor beta? J Invest Dermatol 2006 126 : 2010 2018. (Pubitemid 44244844)
14. Ebling FJ. Hair. J Invest Dermatol. 1976 67 : 98 105.
15. Thornton MJ, Taylor AH, Mulligan K et al. Oestrogen receptor beta is the predominant oestrogen receptor in human scalp skin. Exp Dermatol 2003 12 : 181 190. (Pubitemid 36939119)
16. Rushton DH, Ramsay ID, James KC et al. Biochemical and trichological characterization of diffuse alopecia in women. Br J Dermatol 1990 123 : 187 197.
17. Schmidt JB, Lindmaier A, Trenz A et al. Hormone studies in females with androgenic hair loss. Gynecol Obstet Invest 1991 31 : 235 239.
18. Price VH, Roberts JL, Hordinsky M et al. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol 2000 43 : 768 776.
19. Vexiau P, Chaspoux C, Boudou P et al. Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial. Br J Dermatol 2002 146 : 992 999. (Pubitemid 34779479)